These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6441614)

  • 1. 6-Hydroxydopamine produces lesions of serotonin-containing Retzius cells in the leech nervous system.
    Lent CM; Santamarina L
    Brain Res; 1984 Dec; 323(2):335-41. PubMed ID: 6441614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin in the leech central nervous system: anatomical correlates and behavioral effects.
    Lent CM; Zundel D; Freedman E; Groome JR
    J Comp Physiol A; 1991 Feb; 168(2):191-200. PubMed ID: 2046044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retzius cells retain functional membrane properties following 'ablation' by the neurotoxin 5,7-DHT.
    Lent CM; Dickinson MH
    Brain Res; 1984 May; 300(1):167-71. PubMed ID: 6329427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamines and serotonin in rat frontal cortex after PCPA and 6-OHDA: absolute amounts and ratios.
    Reader TA
    Brain Res Bull; 1982 May; 8(5):527-34. PubMed ID: 6214300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats.
    Berger TW; Kaul S; Stricker EM; Zigmond MJ
    Brain Res; 1985 Jun; 336(2):354-8. PubMed ID: 3924346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatographic and histochemical identification of dopamine within an identified neuron in the leech nervous system.
    Lent CM; Mueller RL; Haycock DA
    J Neurochem; 1983 Aug; 41(2):481-90. PubMed ID: 6875548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of catecholamine terminals and intrinsic neurons of the ventral tegmentum in self-stimulation investigated in neonatally dopamine-depleted rats.
    Takeichi T; Kurumiya S; Umemoto M; Olds ME
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1101-9. PubMed ID: 3086902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 6-hydroxydopamine on dopamine and noradrenaline content in dog blood vessels and heart. Evidence for a noradrenaline-independent dopamine pool.
    Soares-da-Silva P; Davidson R
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):253-7. PubMed ID: 3927177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
    Javoy F; Sotelo C; Herbet A; Agid Y
    Brain Res; 1976 Feb; 102(2):201-15. PubMed ID: 1247882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell lineage, cell death, and the developmental origin of identified serotonin- and dopamine-containing neurons in the leech.
    Stuart DK; Blair SS; Weisblat DA
    J Neurosci; 1987 Apr; 7(4):1107-22. PubMed ID: 3553443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irritable aggression induced by delta 9-tetrahydrocannabinol in rats pretreated with 6-hydroxydopamine.
    Fujiwara M; Kataoka Y; Hori Y; Ueki S
    Pharmacol Biochem Behav; 1984 Mar; 20(3):457-62. PubMed ID: 6324245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic agents: influence on serotonin in the molluscan nervous system.
    Stefano GB; Catapane E; Aiello E
    Science; 1976 Oct; 194(4264):539-41. PubMed ID: 973139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of neonatal 6-hydroxydopamine administration on the catecholaminergic structures of the hypothalamus and on the behavior of rats of various ages].
    Konstantinova MS; Semenova TP; Grishchenko NI; Gromova EA; Polenov AL
    Ontogenez; 1989; 20(3):332-6. PubMed ID: 2549482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of cerebral cortex in the rat following prenatal administration of 6-hydroxydopamine.
    Lidov HG; Molliver ME
    Brain Res; 1982 Jan; 255(1):81-108. PubMed ID: 6799150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of intracranial injections of 6-OHDA and guanethidine on consummatory behavior and monoamine depletion.
    Singer G; Armstrong S; Evans B; Burnstock G
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):91-106. PubMed ID: 1226403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment.
    Cross RJ; Jackson JC; Brooks WH; Sparks DL; Markesbery WR; Roszman TL
    Immunology; 1986 Jan; 57(1):145-52. PubMed ID: 3080368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin.
    Santiago RM; Barbiero J; Gradowski RW; Bochen S; Lima MM; Da Cunha C; Andreatini R; Vital MA
    Behav Brain Res; 2014 Feb; 259():70-7. PubMed ID: 24183944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.